AstraZeneca Joins Ambitious Push to Save 100,000 Lives from Prostate Cancer

Astrazeneca logo

 

AstraZeneca has joined ZERO's Blitz the Barriers initiative as a founding partner, reinforcing the most ambitious prostate cancer program in U.S. history — to save 100,000 lives by 2035 by closing survival gaps in the nation's highest-risk communities.

Read the full article here.


Learn more about our early detection and health equity initiatives through Blitz the Barriers.

Share